We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.105 | 2.26% | 4.755 | 4.52 | 4.99 | - | 189,060 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/6/2020 20:22 | Hi Guys Any chance of joining the guild. Kinda useless on here without membership Thx in advance | holidaze | |
02/6/2020 20:16 | 6 year history now - Dumped by AstraZeneca re SNG001 Never once backed from 2014 on, by any insider with a standard buy ............. Now in AZNs time in-licence re SNG, they would have learned a lot about this, obviously. RIGHT? The approach, everything. Not only did they dump it mid-trial.......... What are their approaches today? The argument by the SNG sayers, will be, this is different. With all this past inside data on SNG001, why have they not used that knowledge to develop similar ? Why other paths? | spartan attack | |
02/6/2020 20:09 | awise355, I've just sent you my one and only coin. | 801710245 | |
02/6/2020 20:05 | Dear Spartan Attack, Now that those of us with an IQ above 12 have a new home - and this one is largely redundant, I've decided to unfilter you. I was interested to see whether you were still as much of a 'weapons-grade-belle My suspicions were confirmed within about 2.5 seconds. If it's any consolation, we're having a 'bring-a-bottle' house warming party, at Nobby's new 'des-res'. Plenty of nibbles - but he's been a bit stingy with the Pringles. Anyway - post away here to your heart's content - laterz, J xx | 801710245 | |
02/6/2020 19:59 | Hi Nobby, can I be accepted into the Guild. Highly appreciative of any non-toxic forum - thanks in advance | awise355 | |
02/6/2020 19:49 | Done. Just click on the thread and I will admit you. Just going out for a walk so there may be a delay before you are admitted. | nobbygnome | |
02/6/2020 19:49 | Its even worse than OPTI and SBTX and thats sayin somethin | spartan attack | |
02/6/2020 19:48 | So we now have: 1. A financial implosion primed, on failure to produce 2. A major, who did not like it then, and didnt even see any value in the approach today. Given their past experience 3. Funds that held average 11,4p with the above risks in place 4. well, 4. 5. 6. 7. and 8... All down to investors :) Technical side tomorrow. Maybe day after...to confirm true sentiment here. Smart sentiment | spartan attack | |
02/6/2020 19:46 | Hi Nobby. Any change of joining the guild please. Cheers. Glenn | glennrcharles | |
02/6/2020 19:45 | 6 year history now - Dumped by AstraZeneca re SNG001 Never once backed from 2014 on, by any insider with a standard buy ............. Now in AZNs time in-licence re SNG, they would have learned a lot about this, obviously. RIGHT? The approach, everything. Not only did they dump it mid-trial.......... What are their approaches today? The argument by the SNG sayers, will be, this is different. With all this past inside data on SNG001, why have they not used that knowledge to develop similar ? Why other paths? | spartan attack | |
02/6/2020 19:33 | I wonder what the reasoned reasoning is on this being effectively dumped already? | spartan attack | |
02/6/2020 19:32 | There is a lot of current sales pitching today, similar to 2014 Lets ignore the 2017 bit | spartan attack | |
02/6/2020 19:31 | You have enough coins. Go to the new thread and click on it. I will then admit you,to the guild. | nobbygnome | |
02/6/2020 19:29 | I can give you some coins if you want them.... | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions